title: Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention.
abstract: BACKGROUND
  Diabetes mellitus (DM) is a significant factor regarding poor outcome in patients with myocardial infarction. Recently a new prognostic factor is under consideration - a baseline glucose level on admission. We sought to assess the influence of blood glucose levels on admission on prognosis of patients with acute ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI).
  
  
  RESULTS
  Consecutive patients treated with PCI for STEMI were analyzed. Presence or absence of DM was the first grouping criterion. The secondary criterion was the blood glucose level on admission [threshold >or= 7.8 mmol/L (140 mg/dL)]. Hyperglycemic and non-hyperglycemic subgroups were selected within both DM and non-DM groups according to the threshold. One-year mortality of diabetics was 16.0%. There was no significant difference in 1-year mortality between hyperglycemic and non-hyperglycemic patients with DM. One-year mortality in the non-DM group was 5.6%. Patients without DM but with hyperglycemia showed a higher 1-year mortality rate than non-hyperglycemic patients (8.51% vs. 3.68%, p = 0.001). Multivariate analysis revealed that in the non-DM group blood glucose level (per 1 mmol/L) on admission was a factor affecting 1-year mortality [HR = 1.09 (1.01-1.17)].
  
  
  CONCLUSIONS
  Elevated blood glucose levels in STEMI affect the prognosis of patients without DM; however, it is not an independent death risk factor of patients with DM treated with PCI.
authors.affiliation: Department of Cardiology, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland. mariuszgasior@poczta.onet.pl
authors.forename: Mariusz
authors.initials: M
authors.lastname: Gasior
authors.forename: Damian
authors.initials: D
authors.lastname: Pres
authors.forename: Gabriela
authors.initials: G
authors.lastname: Stasik-Pres
authors.forename: Piotr
authors.initials: P
authors.lastname: Lech
authors.forename: Marek
authors.initials: M
authors.lastname: Gierlotka
authors.forename: Michał
authors.initials: M
authors.lastname: Hawranek
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Wilczek
authors.forename: Bozena
authors.initials: B
authors.lastname: Szyguła-Jurkiewicz
authors.forename: Andrzej
authors.initials: A
authors.lastname: Lekston
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kalarus
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Strojek
authors.forename: Janusz
authors.initials: J
authors.lastname: Gumprecht
authors.forename: Lech
authors.initials: L
authors.lastname: Poloński
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000401:mortality*; D001786:Blood Glucose / Q000378:metabolism; D017023:Coronary Angiography; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006943:Hyperglycemia / Q000378:metabolism / Q000401:mortality*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000628:therapy*; D011237:Predictive Value of Tests; D011379:Prognosis; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D001786:Blood Glucose